TY - JOUR
T1 - Health-Related Quality of Life and Emotional Difficulties in Chronic Granulomatous Disease: Data on Adult and Pediatric Patients from Italian Network for Primary Immunodeficiency (IPINet)
AU - Pulvirenti, Federica
AU - Sangerardi, Maria
AU - Plebani, Alessandro
AU - Soresina, Annarosa
AU - Finocchi, Andrea
AU - Pignata, Claudio
AU - Cirillo, Emilia
AU - Trizzino, Antonino
AU - Aiuti, Alessandro
AU - Migliavacca, Maddalena
AU - Locatelli, Franco
AU - Bertaina, Alice
AU - Naviglio, Samuele
AU - Carrabba, Maria
AU - De Carli, Marco
AU - Barbaro, Maria Grazia Foschino
AU - Gattorno, Marco
AU - Quinti, Isabella
AU - Martire, Baldassarre
PY - 2020
Y1 - 2020
N2 - Chronic granulomatous disease (CGD) is a primary immunodeficiency characterized by life-threatening infections, inflammation, and autoimmunity with an impact on health-related quality of life (HRQoL). Few data are available for children, whereas no study has been conducted in adults. Here, we investigated HRQoL and emotional functioning of 19 children and 28 adults enrolled in Italian registry for CGD. PEDsQL and SDQ were used for children and their caregivers, and adults completed the SF-12 questionnaire. Mean scores were compared with norms and with patients affected by chronic diseases. Comparisons were made for CGD patients who underwent or not hematopoietic stem cell transplantation (HSCT). When compared with norms, CGD children exhibited higher difficulties in social/school areas, peer relationship, and conduct/emotional problems (< 5 years of age), as scored by proxies. Differently, CGD adults reported higher difficulties both in mental and physical area than norms. Only for children, clinical status had a damaging effect on psychosocial and school dimensions, whereas age had a negative impact on social areas. No significant difference was observed between patients treated or not with HSCT. When compared with patients affected by chronic diseases, CGD children and adults both displayed fewer physical disabilities. Differently, in mental scale adults scored lower than those with rheumatology diseases and had similar impairment in comparison with patients with diabetes mellitus and cancer. This study emphasized the impact of CGD on HRQoL since infancy and its decline in adulthood, with emotional difficulties occurring early. HRQoL impairment should be considered in clinical picture of CGD and pro-actively assessed and managed by clinicians.
AB - Chronic granulomatous disease (CGD) is a primary immunodeficiency characterized by life-threatening infections, inflammation, and autoimmunity with an impact on health-related quality of life (HRQoL). Few data are available for children, whereas no study has been conducted in adults. Here, we investigated HRQoL and emotional functioning of 19 children and 28 adults enrolled in Italian registry for CGD. PEDsQL and SDQ were used for children and their caregivers, and adults completed the SF-12 questionnaire. Mean scores were compared with norms and with patients affected by chronic diseases. Comparisons were made for CGD patients who underwent or not hematopoietic stem cell transplantation (HSCT). When compared with norms, CGD children exhibited higher difficulties in social/school areas, peer relationship, and conduct/emotional problems (< 5 years of age), as scored by proxies. Differently, CGD adults reported higher difficulties both in mental and physical area than norms. Only for children, clinical status had a damaging effect on psychosocial and school dimensions, whereas age had a negative impact on social areas. No significant difference was observed between patients treated or not with HSCT. When compared with patients affected by chronic diseases, CGD children and adults both displayed fewer physical disabilities. Differently, in mental scale adults scored lower than those with rheumatology diseases and had similar impairment in comparison with patients with diabetes mellitus and cancer. This study emphasized the impact of CGD on HRQoL since infancy and its decline in adulthood, with emotional difficulties occurring early. HRQoL impairment should be considered in clinical picture of CGD and pro-actively assessed and managed by clinicians.
KW - burden of disease
KW - Chronic granulomatous disease
KW - emotional difficulties
KW - SF-12
KW - hematopoietic stem cell transplantation
KW - PEDsQL
KW - SDQ
KW - health-related quality of life
KW - burden of disease
KW - Chronic granulomatous disease
KW - emotional difficulties
KW - SF-12
KW - hematopoietic stem cell transplantation
KW - PEDsQL
KW - SDQ
KW - health-related quality of life
UR - http://hdl.handle.net/10807/229755
U2 - 10.1007/s10875-019-00725-1
DO - 10.1007/s10875-019-00725-1
M3 - Article
SN - 0271-9142
VL - 40
SP - 289
EP - 298
JO - Journal of Clinical Immunology
JF - Journal of Clinical Immunology
ER -